Innovative ultrasound technique enhances liver surgery outcomes
A novel ultrasound-guided technique to compress the middle hepatic vein allows for better detection of left-sided communicating veins, improving surgical options.
Newsletter
HPB & Spleen
Every new paper in this field, in your inbox.
Surgery Alone Improves Outcomes in Resectable Pancreatic Cancer
Surgical resection without multimodal treatment for early-stage pancreatic cancer can lead to better survival outcomes.
Novel Risk Score Predicts Pancreatic Fistula After Surgery
A new preoperative scoring system enhances risk stratification for clinically relevant postoperative pancreatic fistula (cr-popf) after pancreatoduodenectomy, potentially improving surgical outcomes.
Understanding Recurrence Patterns Post-Colorectal Liver Metastasis Surgery
Tailored postoperative surveillance can significantly improve outcomes for colorectal liver metastases patients.
Minimally Invasive Approach Shows Strong Outcomes for Gallbladder Cancer
Minimally invasive radical cholecystectomy provides promising long-term survival for gallbladder cancer patients.
Perineural invasion worsens survival in resected pancreatic tumors
Patients with pancreatic neuroendocrine tumors (PNETs) and perineural invasion (PNI) face significantly worse outcomes post-surgery.
Robotic Surgery Enhances Caudate Lobe Resection Outcomes
Robotic-assisted surgery significantly improves the feasibility of caudate lobe resections for hepatobiliary surgeons.
Revolutionary Prognostic Tool for Intrahepatic Cholangiocarcinoma
A novel grading system combining CA19-9, CA125, and CEA significantly improves prognostic accuracy for intrahepatic cholangiocarcinoma patients post-surgery.
New scoring tool predicts pancreatic fistula risk in surgery
A new preoperative risk score based on CT measurements can help surgeons predict clinically relevant postoperative pancreatic fistula (cr-popf) after pancreatoduodenectomy.
Neoadjuvant Chemotherapy Boosts Survival in Intrahepatic Cholangiocarcinoma
Neoadjuvant chemotherapy followed by surgery significantly improves outcomes for potentially resectable intrahepatic cholangiocarcinoma compared to upfront surgery.